Broderick Brian C - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
Broderick Brian C ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$2,955,468
+6.2%
29,015
+5.2%
0.81%
+10.7%
Q2 2023$2,784,106
+8.3%
27,590
-1.3%
0.74%
+1.8%
Q1 2023$2,571,400
-0.5%
27,950
-1.8%
0.72%
-5.7%
Q4 2022$2,583,252
+11.8%
28,475
-6.3%
0.77%
+6.1%
Q3 2022$2,311,000
-15.6%
30,405
-6.1%
0.72%
-13.0%
Q2 2022$2,737,000
-13.9%
32,385
-10.6%
0.83%
+2.2%
Q1 2022$3,179,000
-11.6%
36,233
-11.8%
0.81%
-6.1%
Q4 2021$3,595,000
-35.7%
41,100
-39.9%
0.86%
-42.1%
Q3 2021$5,593,000
-23.8%
68,395
-15.0%
1.49%
-23.5%
Q2 2021$7,344,000
+0.6%
80,504
-5.7%
1.95%
-7.1%
Q1 2021$7,297,000
-10.4%
85,373
-1.0%
2.10%
-13.2%
Q4 2020$8,143,000
+8.1%
86,220
-0.5%
2.42%
+0.8%
Q3 2020$7,535,000
+0.7%
86,645
+1.1%
2.40%
-3.8%
Q2 2020$7,485,000
+5.1%
85,704
-0.8%
2.49%
-11.6%
Q1 2020$7,123,000
-12.7%
86,387
+0.2%
2.82%
+6.6%
Q4 2019$8,160,000
+8.2%
86,175
-0.7%
2.64%
+1.8%
Q3 2019$7,543,000
-5.5%
86,802
-0.8%
2.60%
-7.1%
Q2 2019$7,986,000
-5.2%
87,465
-0.1%
2.79%
-7.1%
Q1 2019$8,422,000
+10.1%
87,595
-1.7%
3.01%
-6.5%
Q4 2018$7,647,000
-3.0%
89,127
-2.6%
3.22%
+20.3%
Q3 2018$7,887,000
+14.4%
91,529
+0.3%
2.68%
+6.2%
Q2 2018$6,892,000
-5.6%
91,267
+1.1%
2.52%
-8.0%
Q1 2018$7,298,000
-3.6%
90,247
+0.0%
2.74%
-1.0%
Q4 2017$7,574,000
-6.4%
90,205
-4.3%
2.76%
-5.3%
Q3 2017$8,091,000
+4.7%
94,237
+1.8%
2.92%
+2.1%
Q2 2017$7,727,000
+14.8%
92,549
+2.1%
2.86%
+4.1%
Q1 2017$6,732,000
+4.2%
90,639
+2.2%
2.75%
-1.9%
Q4 2016$6,459,000
-8.2%
88,656
-0.5%
2.80%
-6.7%
Q3 2016$7,039,000
-5.8%
89,136
-1.5%
3.00%
-4.5%
Q2 2016$7,469,000
+18.0%
90,526
+3.7%
3.14%
+14.7%
Q1 2016$6,327,000
-9.1%
87,331
+7.9%
2.74%
-12.0%
Q4 2015$6,959,000
-6.5%
80,901
-0.1%
3.11%
-9.7%
Q3 2015$7,446,000
-6.3%
81,009
+0.2%
3.45%
+1.9%
Q2 2015$7,950,000
-1.7%
80,819
-1.5%
3.39%
+0.9%
Q1 2015$8,088,000
+7.3%
82,030
+0.8%
3.36%
+5.1%
Q4 2014$7,539,000
+5.5%
81,370
+7.1%
3.19%
+0.4%
Q3 2014$7,148,000
+4.8%
75,945
+0.8%
3.18%
+1.8%
Q2 2014$6,822,000
+9.7%
75,354
+3.0%
3.12%
+2.2%
Q1 2014$6,219,000
+5.8%
73,149
+0.0%
3.06%
+4.4%
Q4 2013$5,879,000
+4.1%
73,139
-0.7%
2.93%
-7.1%
Q3 2013$5,649,000
+8.5%
73,639
-0.0%
3.15%
+1.1%
Q2 2013$5,208,000
-0.3%
73,664
+0.5%
3.12%
+0.5%
Q1 2013$5,225,000
+16.7%
73,324
+3.7%
3.10%
-2.3%
Q4 2012$4,476,00070,7043.17%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders